Ourania Tatsis

EVP, Chief Reg. & Quality Off., Vertex Pharmaceuticals

Bought, 12 months

$0.0M

Sold, 12 months

$6.5M

Companies

Latest trade

Jul 2, 2026

Companies

Vertex PharmaceuticalsEVP, Chief Reg. & Quality Off. −$6.5M

Trades

VRTX Sold 1,500 shares at $524.99 · planned $0.8M Jul 2

VRTX Sold 260 shares at $486.35 · planned $0.1M Feb 25

VRTX Sold 368 shares at $473.68 · planned $0.2M Feb 18

VRTX Sold 609 shares at $489.46 · planned $0.3M Feb 17

VRTX Sold 1,500 shares at $499.99 · planned $0.7M Feb 13

VRTX Sold 466 shares at $460.43 · planned $0.2M Feb 11

VRTX Sold 4,500 shares at $474.99 · planned $2.1M Jan 7

VRTX Sold 4,500 shares at $449.99 · planned $2.0M Dec 3

Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.